ProMIS Neurosciences, Inc.
PMN
$0.52
$0.0193.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 4.32M | 2.56M | 1.63M | 2.12M | 2.23M |
| Gross Profit | -4.32M | -2.56M | -1.63M | -2.12M | -2.23M |
| SG&A Expenses | -1.82M | 1.87M | 1.09M | 1.55M | 1.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.50M | 4.43M | 2.71M | 3.68M | 3.87M |
| Operating Income | -2.50M | -4.43M | -2.71M | -3.68M | -3.87M |
| Income Before Tax | -238.20K | 9.28M | -2.62M | -3.64M | -3.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -238.20K | 9.28M | -2.62M | -3.64M | -3.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -238.20K | 9.28M | -2.62M | -3.64M | -3.58M |
| EBIT | -2.50M | -4.43M | -2.71M | -3.68M | -3.87M |
| EBITDA | -2.50M | -4.43M | -2.71M | -3.67M | -3.86M |
| EPS Basic | -0.01 | 0.31 | -0.13 | -0.19 | -0.18 |
| Normalized Basic EPS | 0.06 | 0.19 | -0.08 | -0.12 | -0.11 |
| EPS Diluted | -0.01 | 0.31 | -0.13 | -0.19 | -0.18 |
| Normalized Diluted EPS | 0.06 | 0.19 | -0.08 | -0.12 | -0.11 |
| Average Basic Shares Outstanding | 34.82M | 30.02M | 19.77M | 19.53M | 19.59M |
| Average Diluted Shares Outstanding | 34.82M | 30.07M | 19.77M | 19.53M | 19.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |